# User Fee Waivers for FDC and Co-Packaged HIV Drugs for PEPFAR - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/user-fee-waivers-for-fdc-and-co-packaged-hiv-drugs-for-pepfar/13c7af5f-84b1-4023-80d0-9ff6cb3357dc

> FDA guidance document: User Fee Waivers for FDC and Co-Packaged HIV Drugs for PEPFAR. Issue date: February 08, 2007. Get complete insights and analysis.

---

## Details

- Title: User Fee Waivers for FDC and Co-Packaged HIV Drugs for PEPFAR
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2007-02-08
- Last Changed: 2020-05-05
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2005-D-0083">FDA-2005-D-0083</a>

## Related Documents

- [Role of HIV Drug Resistance Testing in Antiretroviral Drug Development](https://www.globalkeysolutions.net/guidances/guidance-document/role-of-hiv-drug-resistance-testing-in-antiretroviral-drug-development/b63afac3-86d1-45b1-bee0-b25944c92926)
- [Nonclinical Safety Evaluation of Pediatric Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/nonclinical-safety-evaluation-of-pediatric-drug-products/a5729b5c-7a6e-40c1-861d-e8acf3cd178a)
- [Prescription Drug Marketing Act — Donation of Prescription Drug Samples to Free Clinics](https://www.globalkeysolutions.net/guidances/guidance-document/prescription-drug-marketing-act-donation-of-prescription-drug-samples-to-free-clinics/703c91fa-8616-445a-8a1e-5ad08e94d3f4)